Ann: VF001 - Clinical Presentation, page-4

Japes, Avita's product is not a direct competitor to FTT's FTT-001 biologic.

Avita" Recell is a "procedure". It involves taking skin and would need to be done by highly trained medical staff in a specialised clinic. It cannot be done in the community setting (ie a nurse or a home care).

FTT's offering is a biologic solution which comes ready-packaged in a syringe and is easily applied as part of the standard care of compression bandaging by a community nurse.

FTT's product will therefore have a much wider and affordable application and thus have a better chance of commercial success, should the clinical trials succeed.